In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- Tuberculosis Treatment market production: Regional Analysis for the United States, Europe, China, and Japan on December 13, 2018 at 11:55 pm
Global Tuberculosis Treatment Market Report is the latest offering at ‘The Market Reports’ which is in-depth analysis of the market and helps an individual or company to understand the market scenario ... […]
- Tuberculosis case spurs testing of students on December 13, 2018 at 6:34 pm
BUFFALO, NY (WIVB)- Nearly two hundred students in the Amherst area have been advised by the Erie County Department of Health to get tested for tuberculosis as they may have come in contact with a mem... […]
- Lung lavage as new test method improves tuberculosis diagnosis in rhinoceros on December 13, 2018 at 6:27 am
Scientists performed repeated lung lavage as a new approach for tuberculosis diagnosis in rhinoceros. Subsequent genetic tests reliably identified mycobacteria in the animals' respiratory fluids -- wi... […]
- GHIT Fund Announces New Investments in Vaccines for Dengue and Leishmaniasis, and Drug Screening for Malaria and Tuberculosis on December 12, 2018 at 5:08 pm
TOKYO, Dec. 12, 2018 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 520 million yen (US$4.6 million*) to support four partnerships to develop new lifesa... […]
- Active tuberculosis case confirmed in individual who works in Williamsville schools on December 12, 2018 at 12:00 pm
(WIVB) - Erie County Health Commissioner Gale Burstein confirmed Wednesday during a press conference that an active case of tuberculosis has been confirmed in an individual who works with children in ... […]
- Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery on December 12, 2018 at 3:45 am
Schrödinger and TB Alliance have entered into a three-year research collaboration to enhance the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced comput... […]
- Tuberculosis exposure possible at MiraCosta, San Diego City Colleges on December 10, 2018 at 3:51 pm
SAN DIEGO (CNS) - The San Diego County Health and Human Services Agency is working in close collaboration with MiraCosta College and San Diego City College officials to notify people who were possibly ... […]
- Tuberculosis cases reported on 2 college campuses on December 10, 2018 at 3:23 pm
SAN DIEGO — San Diego County officials announced Monday they are working with officials from MiraCosta College and San Diego City College to notify people who may have been exposed to ... […]
- Tuberculosis Cases Reported At Two Colleges In San Diego County on December 10, 2018 at 2:11 pm
SAN DIEGO COUNTY, CA – Health officials said Monday they are working to notify people who may have been exposed to tuberculosis at two college campuses in San Diego County. The unrelated ... […]
- Inuit Tuberculosis Elimination Framework Released on December 10, 2018 at 6:45 am
OTTAWA, Dec. 10, 2018 /CNW/ - Today, the Inuit Tuberculosis Elimination Framework was released by Inuit Tapiriit Kanatami as a next step in ongoing efforts to address staggeringly high rates of tuberc... […]
via Google News and Bing News